2021 年的期刊文章 · 第 19 页

共 1542 篇,按发表时间排,新的在前,每页 40 篇。这一页是 2021-05-11 到 2021-05-04。

按期刊、按主题看 →

第 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 页

SiM Spatial & Time Series · 发表于 2021-05-11

Monitoring COVID‐19 contagion growth

Arianna Agosto, Alexandra Campmas, Paolo Giudici, Andrea Renda

摘要

We present a statistical model that can be employed to monitor the time evolution of the COVID‐19 contagion curve and the associated reproduction rate. The model is a Poisson autoregression of the daily new observed cases and dynamically adapt its estimates to explain the evolution of contagion in terms of a short‐term and long‐term dependence of case counts, allowing for a comparative evaluation of health policy measures. We have applied the model to 2020 data from the countries most hit by the virus. Our empirical findings show that the proposed model describes the evolution of contagion dynamics and determines whether contagion growth can be affected by health policies. Based on our findings, we can draw two health policy conclusions that can be useful for all countries in the world. First, policy measures aimed at reducing contagion are very useful when contagion is at its peak to reduce the reproduction rate. Second, the contagion curve should be accurately monitored over time to apply policy measures that are cost‐effective.

SiM Nonparametric & Semiparametric · 发表于 2021-05-11

Enhanced empirical likelihood estimation of incubation period of COVID‐19 by integrating published information

Zhongfeng Jiang, Baoying Yang, Jing Qin, Yong Zhou

摘要

Since the outbreak of the new coronavirus disease (COVID‐19), a large number of scientific studies and data analysis reports have been published in the International Journal of Medicine and Statistics. Taking the estimation of the incubation period as an example, we propose a low‐cost method to integrate external research results and available internal data together. By using empirical likelihood method, we can effectively incorporate summarized information even if it may be derived from a misspecified model. Taking the possible uncertainty in summarized information into account, we augment a logarithm of the normal density in the log empirical likelihood. We show that the augmented log‐empirical likelihood can produce enhanced estimates for the underlying parameters compared with the method without utilizing auxiliary information. Moreover, the Wilks' theorem is proved to be true. We illustrate our methodology by analyzing a COVID‐19 incubation period data set retrieved from Zhejiang Province and summarized information from a similar study in Shenzhen, China.

SiM Causal Inference · 发表于 2021-05-10

The impact of adjusting for pure predictors of exposure, mediator, and outcome on the variance of natural direct and indirect effect estimators

Awa Diop, Geneviève Lefebvre, Caroline S. Duchaine, Danielle Laurin, Denis Talbot

摘要

It is now well established that adjusting for pure predictors of the outcome, in addition to confounders, allows unbiased estimation of the total exposure effect on an outcome with generally reduced standard errors (SEs). However, no analogous results have been derived for mediation analysis. Considering the simplest linear regression setting and the ordinary least square estimator, we obtained theoretical results showing that adjusting for pure predictors of the outcome, in addition to confounders, allows unbiased estimation of the natural indirect effect (NIE) and the natural direct effect (NDE) on the difference scale with reduced SEs. Adjusting for pure predictors of the mediator increases the SE of the NDE's estimator, but may increase or decrease the variance of the NIE's estimator. Adjusting for pure predictors of the exposure increases the variance of estimators of the NIE and NDE. Simulation studies were used to confirm and extend these results to the case where the mediator or the outcome is binary. Additional simulations were conducted to explore scenarios featuring an exposure‐mediator interaction as well as the relative risk and odds ratio scales for the case of binary mediator and outcome. Both a regression approach and an inverse probability weighting approach were considered in the simulation study. A real‐data illustration employing data from the Canadian Study of Health and Aging is provided. This analysis is concerned with the mediating effect of vitamin D in the effect of physical activity on dementia and its results are overall consistent with the theoretical and empirical findings.

JASA Causal Inference Longitudinal Data · 发表于 2021-05-10

Matrix Completion Methods for Causal Panel Data Models

Susan Athey, Mohsen Bayati, Nikolay Doudchenko, Guido Imbens, Khashayar Khosravi

摘要

In this article, we study methods for estimating causal effects in settings with panel data, where some units are exposed to a treatment during some periods and the goal is estimating counterfactual (untreated) outcomes for the treated unit/period combinations. We propose a class of matrix completion estimators that uses the observed elements of the matrix of control outcomes corresponding to untreated unit/periods to impute the “missing” elements of the control outcome matrix, corresponding to treated units/periods. This leads to a matrix that well-approximates the original (incomplete) matrix, but has lower complexity according to the nuclear norm for matrices. We generalize results from the matrix completion literature by allowing the patterns of missing data to have a time series dependency structure that is common in social science applications. We present novel insights concerning the connections between the matrix completion literature, the literature on interactive fixed effects models and the literatures on program evaluation under unconfoundedness and synthetic control methods. We show that all these estimators can be viewed as focusing on the same objective function. They differ solely in the way they deal with identification, in some cases solely through regularization (our proposed nuclear norm matrix completion estimator) and in other cases primarily through imposing hard restrictions (the unconfoundedness and synthetic control approaches). The proposed method outperforms unconfoundedness-based or synthetic control estimators in simulations based on real data. *(abstract via OpenAlex)*

JASA Networks & Graphs High-Dimensional · 发表于 2021-05-10

Hierarchical Network Models for Exchangeable Structured Interaction Processes

Walter Dempsey, Brandon Oselio, Alfred Hero

摘要

Network data often arises via a series of structured interactions among a population of constituent elements. E-mail exchanges, for example, have a single sender followed by potentially multiple receivers. Scientific articles, on the other hand, may have multiple subject areas and multiple authors. We introduce a statistical model, termed the Pitman-Yor hierarchical vertex components model (PY-HVCM), that is well suited for structured interaction data. The proposed PY-HVCM effectively models complex relational data by partial pooling of local information via a latent, shared population-level distribution. The PY-HCVM is a canonical example of hierarchical vertex components models - a subfamily of models for exchangeable structured interaction-labeled networks, i.e., networks invariant to interaction relabeling. Theoretical analysis and supporting simulations provide clear model interpretation, and establish global sparsity and power law degree distribution. A computationally tractable Gibbs sampling algorithm is derived for inferring sparsity and power law properties of complex networks. We demonstrate the model on both the Enron e-mail dataset and an ArXiv dataset, showing goodness of fit of the model via posterior predictive validation. *(abstract via PubMed)*

SMMR Longitudinal Data Survival Analysis · 发表于 2021-05-10

Functional joint models for chronic kidney disease in kidney transplant recipients

Jianghu Dong, Jiguo Cao, Jagbir Gill, Clifford Miles, Troy Plumb

摘要

This functional joint model paper is motivated by a chronic kidney disease study post kidney transplantation. The available kidney organ is a scarce resource because millions of end-stage renal patients are on the waiting list for kidney transplantation. The life of the transplanted kidney can be extended if the progression of the chronic kidney disease stage can be slowed, and so a major research question is how to extend the transplanted kidney life to maximize the usage of the scarce organ resource. The glomerular filtration rate is the best test to monitor the progression of the kidney function, and it is a continuous longitudinal outcome with repeated measures. The patient’s survival status is characterized by time-to-event outcomes including kidney transplant failure, death with kidney function, and death without kidney function. Few studies have been carried out to simultaneously investigate these multiple clinical outcomes in chronic kidney disease stage patients based on a joint model. Therefore, this paper proposes a new functional joint model from this clinical chronic kidney disease study. The proposed joint models include a longitudinal sub-model with a flexible basis function for subject-level trajectories and a competing-risks sub-model for multiple time-to event outcomes. The different association structures can be accomplished through a time-dependent function of shared random effects from the longitudinal process or the whole longitudinal history in the competing-risks sub-model. The proposed joint model that utilizes basis function and competing-risks sub-model is an extension of the standard linear joint models. The application results from the proposed joint model can supply some useful clinical references for chronic kidney disease study post kidney transplantation.

Biometrics Survival Analysis Clinical Trials · 发表于 2021-05-10

Feature screening with large‐scale and high‐dimensional survival data

Grace Y. Yi, Wenqing He, Raymond. J. Carroll

摘要

Data with a huge size present great challenges in modeling, inferences, and computation. In handling big data, much attention has been directed to settings with “largepsmalln”, and relatively less work has been done to address problems withpandnbeing both large, though data with such a feature have now become more accessible than before, whereprepresents the number of variables andnstands for the sample size. The big volume of data does not automatically ensure good quality of inferences because a large number of unimportant variables may be collected in the process of gathering informative variables. To carry out valid statistical analysis, it is imperative to screen out noisy variables that have no predictive value for explaining the outcome variable. In this paper, we develop a screening method for handling large‐sized survival data, where the sample sizenis large and the dimensionpof covariates is of non‐polynomial order of the sample sizen, or the so‐called NP‐dimension. We rigorously establish theoretical results for the proposed method and conduct numerical studies to assess its performance. Our research offers multiple extensions of existing work and enlarges the scope of high‐dimensional data analysis. The proposed method capitalizes on the connections among useful regression settings and offers a computationally efficient screening procedure. Our method can be applied to different situations with large‐scale data including genomic data.

Biometrika Genetics & Omics · 发表于 2021-05-10

Estimation of genetic correlation with summary association statistics

Jianqiao Wang, Hongzhe Li

SiM Other · 发表于 2021-05-09

Vaccine adverse event enrichment tests

Shuoran Li, Lili Zhao

摘要

Vaccination safety is critical for individual and public health. Many existing methods have been used to conduct safety studies with the VAERS (Vaccine Adverse Event Reporting System) database. However, these methods frequently identify many adverse event (AE) signals and they are often hard to interpret in a biological context. The AE ontology introduces biologically meaningful structures to the Vaccine Adverse Event Reporting System (VAERS) database by connecting similar AEs, which provides meaningful interpretation for the underlying safety issues. In this paper, we develop rigorous statistical methods to identify “interesting" AE groups by performing AE enrichment analysis. We extend existing gene enrichment tests to perform AE enrichment analysis, while incorporating the special features of the AE data. The proposed methods were evaluated using simulation studies and were further illustrated on two studies using VAERS data. The proposed methods were implemented in R package AEenrich and can be installed from the Comprehensive R Archive Network, CRAN, and source code are available at https://github.com/umich‐biostatistics/AEenrich.

SiM Diagnostics & Prediction Bayesian Methods Latent Variables & Mixtures · 发表于 2021-05-09

Measuring rater bias in diagnostic tests with ordinal ratings

Chanmin Kim, Xiaoyan Lin, Kerrie P. Nelson

摘要

Diagnostic tests are frequently reliant upon the interpretation of images by skilled raters. In many clinical settings, however, the variability observed between experts' ratings plays a detrimental role in the degree of confidence in these interpretations, leading to uncertainty in the diagnostic process. For example, in breast cancer testing, radiologists interpret mammographic images, while breast biopsy results are examined by pathologists. Each of these procedures involves elements of subjectivity. We propose here a flexible two‐stage Bayesian latent variable model to investigate how the skills of individual raters impact the diagnostic accuracy of image‐related testing in large‐scale medical testing studies. A strength of the proposed model is that the true disease status of a patient within a reasonable time frame may or may not be known. In these studies, many raters each contribute classifications on a large sample of patients using a defined ordinal grading scale, leading to a complex correlation structure between ratings. Our modeling approach considers the different sources of variability contributed by experts and patients while accounting for correlations present between ratings and patients, in contrast to currently available methods. We propose a novel measure of a rater's ability (magnifier) that, in contrast to conventional measures of sensitivity and specificity, is robust to the underlying prevalence of disease in the population, providing an alternative measure of diagnostic accuracy across patient populations. Extensive simulation studies demonstrate lower bias in estimation of parameters and measures of accuracy, and illustrate outperformance of the proposed model when compared with existing models. Receiver operator characteristic curves are derived to assess the diagnostic accuracy of individual experts and their overall performance. Our proposed modeling approach is applied to a large breast imaging study for known disease status and a uterine cancer dataset for unknown disease status.

SiM Survival Analysis · 发表于 2021-05-09

Fine‐Gray subdistribution hazard models to simultaneously estimate the absolute risk of different event types: Cumulative total failure probability may exceed 1

Peter C. Austin, Ewout W. Steyerberg, Hein Putter

摘要

The Fine‐Gray subdistribution hazard model has become the default method to estimate the incidence of outcomes over time in the presence of competing risks. This model is attractive because it directly relates covariates to the cumulative incidence function (CIF) of the event of interest. An alternative is to combine the different cause‐specific hazard functions to obtain the different CIFs. A limitation of the subdistribution hazard approach is that the sum of the cause‐specific CIFs can exceed 1 (100%) for some covariate patterns. Using data on 9479 patients hospitalized with acute myocardial infarction, we estimated the cumulative incidence of both cardiovascular death and non‐cardiovascular death for each patient. We found that when using subdistribution hazard models, approximately 5% of subjects had an estimated risk of 5‐year all‐cause death (obtained by combining the two cause‐specific CIFs obtained from subdistribution hazard models) that exceeded 1. This phenomenon was avoided by using the two cause‐specific hazard models. We provide a proof that the sum of predictions exceeds 1 is a fundamental problem with the Fine‐Gray subdistribution hazard model. We further explored this issue using simulations based on two different types of data‐generating process, one based on subdistribution hazard models and other based on cause‐specific hazard models. We conclude that care should be taken when using the Fine‐Gray subdistribution hazard model in situations with wide risk distributions or a high cumulative incidence, and if one is interested in the risk of failure from each of the different event types.

SiM Other · 发表于 2021-05-08

Thoughts on “AIDSandCOVID‐19: A Tale of Two Pandemics and the Role of Statisticians” by Susan S. Ellenberg and Jeffrey S. Morris

Mitchell H. Gail

摘要

Human immunodeficiency virus and Covid‐19 (or SARS‐CoV‐2) differ in their incubation distributions and in their susceptibility to immunologic defense. These features affect our ability to predict the course of these epidemics and to control them.

SiM Clinical Trials Causal Inference · 发表于 2021-05-08

Target estimands for efficient decision making: Response to comments on “Assessing the performance of population adjustment methods for anchored indirect comparisons: A simulation study”

David M. Phillippo, Sofia Dias, Anthony E. Ades, Nicky J. Welton

摘要

We thank Remiro-Azócar, Heath, and Baio (R-AHB) for their letter to the editor, 1 in response to our recent paper presenting a simulation study comparing the performance of methods for population-adjusted indirect comparison. 2 R-AHB discuss the important issue of target estimands with non-collapsible effect measures, expanding upon the discussion in sections 4.3 and 7 of our paper.2 R-AHB distinguish between marginal and conditional treatment effect estimates and explain that matchingadjusted indirect comparison (MAIC) targets marginal effects whereas simulated treatment comparison (STC) and multilevel network meta-regression (ML-NMR) target conditional treatment effects.They conclude that "methods like MAIC are valid for population-based inference, but not 'fit for purpose' when inference is at the individual level, whereas methods like ML-NMR are valid for inference at the individual level, but not designed for population-based inference."Furthermore, they assert that marginal treatment effect estimates are necessary for population-based inference as required for decision-making in Health Technology Assessment (HTA).We welcome and encourage debate of these issues, which-despite much discussion in the literature on randomised controlled trials [3][4][5][6] and observational epidemiology 7-9 -have largely been overlooked in the literature on population adjustment and metaanalysis to date.However, whilst we agree with R-AHB that population-based inference is required for HTA, we disagree that methods like ML-NMR are not appropriate to obtain population-average estimates for HTA.In this response, we further clarify the use of conditional estimates to inform population-average treatment effects and why we believe these are appropriate target estimands for decision making.We also correct some important inaccuracies in R-AHB's letter regarding the characterisation of the methods (in particular ML-NMR) and interpretation of our simulation study results.How to cite this article: Phillippo, D. *(abstract via OpenAlex)*

SiM Other · 发表于 2021-05-08

Statistical successes and failures during the COVID‐19 pandemic: Comments on Ellenberg and Morris

Natalie Dean

摘要

The ongoing HIV/AIDS and COVID-19 pandemics have exerted an extraordinary effect on human health, and they are prime examples of the unique and ever-present threat of emerging infectious diseases. In their article, Ellenberg and Morris describe the critical role of statistical thinking in responding to both pandemics. This includes modeling the outbreak, tracking reporting trends, characterizing the natural history of disease, and evaluating interventions. Statisticians have a unique opportunity to contribute during public health crises, to ensure that analyses are rigorous, inference is sound, and policy decisions are driven by the data. *(abstract via OpenAlex)*

SiM Survival Analysis Nonparametric & Semiparametric · 发表于 2021-05-08

Semiparametric analysis of zero‐inflated recurrent events with a terminal event

Chenchen Ma, Tao Hu, Zhantao Lin

摘要

Recurrent event data frequently arise in longitudinal studies and observations on recurrent events could be terminated by a major failure event such as death. In many situations, there exist a large fraction of subjects without any recurrent events of interest. Among these subjects, some are unsusceptible to recurrent events, while others are susceptible but have no recurrent events being observed due to censoring. In this article, we propose a zero‐inflated generalized joint frailty model and a sieve maximum likelihood approach to analyze zero‐inflated recurrent events with a terminal event. The model provides a considerable flexibility in formulating the effects of covariates on both recurrent events and the terminal event by specifying various transformation functions. In addition, Bernstein polynomials are employed to approximate the unknown cumulative baseline hazard (intensity) function. The estimation procedure can be easily implemented and is computationally fast. Extensive simulation studies are conducted and demonstrate that our proposed method works well for practical situations. Finally, we apply the method to analyze myocardial infarction recurrences in the presence of death in a clinical trial with cardiovascular outcomes.

SiM Other · 发表于 2021-05-08

On the role of statisticians and modelers in responding to AIDS and COVID‐19

Britta L. Jewell, Nicholas P. Jewell

摘要

R01AI148127We appreciate the opportunity to make some comments regarding the role of statisticians and modelers in responding to infectious disease outbreaks, stimulated by the insightful review of these topics by our colleagues Susan Ellenberg and Jeffrey Morris *(abstract via OpenAlex)*

SMMR Survival Analysis · 发表于 2021-05-08

Estimation of covariate effects on net survivals in the relative survival progressive illness-death model

Leyla Azarang, Roch Giorgi, the CENSUR working survival group

摘要

Recently, there has been a lot of development in relative survival field. In the absence of data on the cause of death, the research has tended to focus on the estimation of survival probability of a cancer (as a disease of interest). In many cancers, one nonfatal event that decreases the survival probability can occur. There are a few methods that assess the role of prognostic factors for multiple types of clinical events while dealing with uncertainty about the cause of death. However, these methods require proportional hazard or Markov assumptions. In practice, one or both of these assumptions might be violated. Violation of the proportional hazard assumption can lead to estimates that are biased, and difficult to interpret and violation of Markov assumption results in inconsistent estimators. In this work, we propose a semi-parametric approach to estimate the possibly time-varying regression coefficients in the likely non-Markov relative survival progressive illness-death model. The performance of the proposed estimator is investigated through simulations. We illustrate our approach using data from a study on rectal cancer resected for cure conducted in two French population-based digestive cancer registries.

SiM Causal Inference · 发表于 2021-05-08

Conflating marginal and conditional treatment effects: Comments on “Assessing the performance of population adjustment methods for anchored indirect comparisons: A simulation study”

Antonio Remiro‐Azócar, Anna Heath, Gianluca Baio

摘要

In this commentary, we highlight the importance of: (1) carefully considering and clarifying whether a marginal or conditional treatment effect is of interest in a population‐adjusted indirect treatment comparison; and (2) developing distinct methodologies for estimating the different measures of effect. The appropriateness of each methodology depends on the preferred target of inference.

SiM Other 讨论 / 评论 · 发表于 2021-05-08

Commentary on the role of statisticians in pandemics

Ron Brookmeyer

摘要

I want to express my appreciation for the thoughtful article by Susan Ellenberg and John Morris that compares and contrasts aspects of HIV/AIDS and COVID-19 and the roles that statisticians are playing in addressing the challenges of these pandemics.1 Public health emergencies require rapid response. Statistical contributions can profoundly inform public policy in health emergencies but only if the contributions are timely. The speed at which the COVID-19 crisis has unfolded has been staggering. The United States surpassed a cumulative COVID-19 death toll of 400 000 within 11 months of the first reported U.S. COVID case. In contrast, the HIV/AIDS cumulative death toll in the United States reached the 400 000 mark more than 16 years after the first AIDS reported case. Statisticians have risen to the enormous challenges presented by the COVID-19 pandemic and are making critical contributions on many fronts. One area that statisticians are contributing is making sense of the myriad of models that try to forecast where the COVID-19 pandemic is heading. All too often COVID-19 model predictions that have appeared both in journals and the popular press are at great odds with each other.2 Similarly, in the early days of HIV/AIDS, there were widely varying model predictions. For example, one of the first projections of the HIV/AIDS used the normal density to extrapolate AIDS incidence trends.3 The extrapolation produced the anomalous prediction of rapidly decreasing AIDS cases despite the fact that all the data showed rising AIDS cases and concluded that the projected total size of the AIDS epidemic in the United States would be about 200 000 cases, a number that subsequently was discredited. The authors of that fallacious report cited William Farr and his work with smallpox in the 1830s for justification. Farr's curves for smallpox epidemics looked like normal curves and the normal density was used only by analogy. But of course, smallpox in the 1800s was neither AIDS in the 1990s nor COVID-19 in 2020. One of the earliest prediction models for COVID-19, also based on empirical extrapolation of curves, forecast that COVID-19 deaths in the United States would drop to near zero by summer 2020,4 a prediction that has also been discredited.5 Lessons learned from both the COVID-19 and HIV/AIDS pandemics are that extrapolation of empirical trend curves, regardless how complicated the functional forms, can lead to very misleading results. Extrapolating COVID-19 death curves is especially perilous because of the relatively short time period between infection and death, and as such, death counts can take sharp abrupt turns just weeks after occurrence of events that are somewhat unpredictable such as community lockdowns, super-spreader events, and high travel days. One parallel between COVID-19 and HIV/AIDS is that case surveillance data is only measuring the tip of the iceberg of the infected population. Statistical approaches are needed to estimate the size of the "hidden population" which refers to asymptomatic infected persons who are silently and unknowingly transmitting the infection to others. Back-calculation is a method that was developed to do that estimation for the HIV-infected population. Back-calculation performs statistical deconvolution to reconstruct historical HIV infection rates and thereby estimate the prevalence of HIV infection by using information about the incubation period of HIV and counts of AIDS.6 Back-calculation relies on accurate estimates of the long and variable incubation period of HIV infection (the median incubation period in the absence of treatment is about 10 years). But, back-calculation methods have limited utility in the context of COVID-19 for several reasons. First, the incubation period of COVID-19 is much shorter (median about 5 days). Second, a significant but uncertain proportion of infected persons may never develop symptoms and thus these asymptomatic persons are not reflected at all in counts of cases, hospitalizations, or deaths. Third, the counts of incident COVID cases reported in surveillance data are more incomplete and unreliable than counts of AIDS cases because of the scarcity of COVID-19 tests early in the pandemic and changing patterns of who shows up for tests. COVID-19 modeling has appropriately focused on the transmission dynamics of infection. Transmission models such as susceptible-exposed-infected -recovered models rely on many assumptions such as how long people remain contagious, and rates of contact between persons, seasonality effects, and the introduction and effectiveness of infection control strategies such as physical distancing, wearing of masks or lockdowns. Agent-based modeling and simulations are important tools for implementing transmission models.7 However, outputs from transmission models represented by smooth colorful curves can provide a false sense of precision and hide uncertainties. Builders of these models need to work especially hard to communicate both to the general public and policy makers the key assumptions that they relied upon. Unfortunately, no guidelines have been published to standardize the results of epidemic prediction models.8 It is critically important that the statistical community advocate for transparency in transmission models. Standards for reporting results from transmission models need to be developed as has been done for clinical trials, observational studies, and systematic reviews. Epidemics present special challenges in estimating time to event distributions (eg, the incubation period distribution). For example, the first study of the incubation period distribution of HIV infection was based on transfusion-associated AIDS cases and statistical methods were needed to address sampling biases in the data due to truncation. Challenges in estimating the incubation period of COVID 19 arise in part because the dates of infection are not known or not known precisely. Widely cited estimates of the COVID-19 incubation period distribution used statistical methods to address these issues.9, 10 Pandemics present challenges in the design and conduct of therapeutic and prevention trials.11 For example, in response to the HIV pandemic, statisticians reconsidered traditional approaches to therapeutic clinical trials and acknowledged that a growing epidemic affecting young people requires study design that address the public health urgency.12 Surrogate markers were considered to shorten the duration of trials. Vaccine trials for highly infectious pathogens present critical design challenges because the size, geographic location, and duration of outbreaks are uncertain. Flexible and responsive vaccine trial designs are required as outbreaks ebb and surge in different locations.13, 14 Important considerations in designing vaccine trials include the trial target population, the randomization approach (eg, cluster vs individual randomization), and selection of trial endpoints (eg, infection, symptomatic disease, severe clinical disease or death.) There will undoubtedly be future pandemics. When there is a new public health crisis, we do not have the luxury of time. To have public health impact, statisticians must rapidly become knowledgeable about different aspects of the pathogen, the natural history of disease, the completeness and accuracy of public health surveillance data, transmission dynamics of the infection, and therapeutic and prevention developments. Statisticians can contribute to a host of issues including prediction and epidemic modeling, complexities in estimating incubation periods and transmission rates, and challenges in designing and conducting trials. Statisticians can also contribute by engaging with the media to increase public understanding of statistical issues in predicting and responding to pandemics. While the statistical problems of current and future pandemics can be expected to vary, there is no doubt that statisticians and statistical science will continue to make impactful contributions that address the challenges of public health emergencies. Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study. Data sharing not applicable to this article as no datasets were generated or analysed during the current study *(abstract via OpenAlex)*

SiM Other · 发表于 2021-05-08

AIDS and COVID: A tale of two pandemics and the role of statisticians

Susan S. Ellenberg, Jeffrey S. Morris

摘要

The world has experienced three global pandemics over the last half‐century: HIV/AIDS, H1N1, and COVID‐19. HIV/AIDS and COVID‐19 are still with us and have wrought extensive havoc worldwide. There are many differences between these two infections and their global impacts, but one thing they have in common is the mobilization of scientific resources to both understand the infection and develop ways to combat it. As was the case with HIV, statisticians have been in the forefront of scientists working to understand transmission dynamics and the natural history of infection, determine prognostic factors for severe disease, and develop optimal study designs to assess therapeutics and vaccines.

SiM Clinical Trials · 发表于 2021-05-07

Contamination: How much can an individually randomized trial tolerate?

Karla Hemming, Monica Taljaard, Mirjam Moerbeek, Andrew Forbes

摘要

Cluster randomization results in an increase in sample size compared to individual randomization, referred to as an efficiency loss. This efficiency loss is typically presented under an assumption of no contamination in the individually randomized trial. An alternative comparator is the sample size needed under individual randomization to detect the attenuated treatment effect due to contamination. A general framework is provided for determining the extent of contamination that can be tolerated in an individually randomized trial before a cluster randomized design yields a larger sample size. Results are presented for a variety of cluster trial designs including parallel arm, stepped‐wedge and cluster crossover trials. Results reinforce what is expected: individually randomized trials can tolerate a surprisingly large amount of contamination before they become less efficient than cluster designs. We determine the point at which the contamination means an individual randomized design to detect an attenuated effect requires a larger sample size than cluster randomization under a nonattenuated effect. This critical rate is a simple function of the design effect for clustering and the design effect for multiple periods as well as design effects for stratification or repeated measures under individual randomization. These findings are important for pragmatic comparisons between a novel treatment and usual care as any bias due to contamination will only attenuate the true treatment effect. This is a bias that operates in a predictable direction. Yet, cluster randomized designs with post‐randomization recruitment without blinding, are at high risk of bias due to the differential recruitment across treatment arms. This sort of bias operates in an unpredictable direction. Thus, with knowledge that cluster randomized trials are generally at a greater risk of biases that can operate in a nonpredictable direction, results presented here suggest that even in situations where there is a risk of contamination, individual randomization might still be the design of choice.

SiM Clinical Trials Bayesian Methods · 发表于 2021-05-07

Bayesian adaptive design for clinical trials in Duchenne muscular dystrophy

Stephen L. Lake, Melanie A. Quintana, Kristine Broglio, Jennifer Panagoulias, Scott M. Berry, Michael A. Panzara

摘要

A Bayesian adaptive design is proposed for a clinical trial in Duchenne muscular dystrophy. The trial was designed to demonstrate treatment efficacy on an ambulatory‐based clinical endpoint and to identify early success on a biomarker (dystrophin protein levels) that can serve as a basis for accelerated approval in the United States. The trial incorporates placebo augmentation using placebo data from past clinical trials. A thorough simulation study was conducted to understand the operating characteristics of the trial. This trial design was selected for the US FDA Complex Innovative Trial Design Pilot Meeting Program and the experience in that program is summarized.

SiM Bayesian Methods Latent Variables & Mixtures · 发表于 2021-05-07

A new regression model for overdispersed binomial data accounting for outliers and an excess of zeros

Roberto Ascari, Sonia Migliorati

摘要

Binary outcomes are extremely common in biomedical research. Despite its popularity, binomial regression often fails to model this kind of data accurately due to the overdispersion problem. Many alternatives can be found in the literature, the beta‐binomial (BB) regression model being one of the most popular. The additional parameter of this model enables a better fit to overdispersed data. It also exhibits an attractive interpretation in terms of the intraclass correlation coefficient. Nonetheless, in many real data applications, a single additional parameter cannot handle the entire excess of variability. In this study, we propose a new finite mixture distribution with BB components, namely, the flexible beta‐binomial (FBB), which is characterized by a richer parameterization. This allows us to enhance the variance structure to account for multiple causes of overdispersion while also preserving the intraclass correlation interpretation. The novel regression model, based on the FBB distribution, exploits the flexibility and large variety of the distribution's possible shapes (which includes bimodality and various tail behaviors). Thus, it succeeds in accounting for several (possibly concomitant) sources of overdispersion stemming from the presence of latent groups in the population, outliers, and excessive zero observations. Adopting a Bayesian approach to inference, we perform an intensive simulation study that shows the superiority of the new regression model over that of the existing ones. Its better performance is also confirmed by three applications to real datasets extensively studied in the biomedical literature, namely, bacteria data, atomic bomb radiation data, and control mice data.

SMMR Survival Analysis · 发表于 2021-05-06

Survival models induced by zero-modified power series discrete frailty: Application with a melanoma data set

Katy C Molina, Vinicius F Calsavara, Vera D Tomazella, Eder A Milani

摘要

Survival models with a frailty term are presented as an extension of Cox’s proportional hazard model, in which a random effect is introduced in the hazard function in a multiplicative form with the aim of modeling the unobserved heterogeneity in the population. Candidates for the frailty distribution are assumed to be continuous and non-negative. However, this assumption may not be true in some situations. In this paper, we consider a discretely distributed frailty model that allows units with zero frailty, that is, it can be interpreted as having long-term survivors. We propose a new discrete frailty-induced survival model with a zero-modified power series family, which can be zero-inflated or zero-deflated depending on the parameter value. Parameter estimation was obtained using the maximum likelihood method, and the performance of the proposed models was performed by Monte Carlo simulation studies. Finally, the applicability of the proposed models was illustrated with a real melanoma cancer data set.

Biometrics Bayesian Methods · 发表于 2021-05-06

Parameter inference for a stochastic kinetic model of expanded polyglutamine proteins

H. F. Fisher, R. J. Boys, C. S. Gillespie, C. J. Proctor, A. Golightly

摘要

The presence of protein aggregates in cells is a known feature of many human age‐related diseases, such as Huntington's disease. Simulations using fixed parameter values in a model of the dynamic evolution of expanded polyglutaime (PolyQ) proteins in cells have been used to gain a better understanding of the biological system. However, there is considerable uncertainty about the values of some of the parameters governing the system. Currently, appropriate values are chosen by ad hoc attempts to tune the parameters so that the model output matches experimental data. The problem is further complicated by the fact that the data only offer a partial insight into the underlying biological process: the data consist only of the proportions of cell death and of cells with inclusion bodies at a few time points, corrupted by measurement error. Developing inference procedures to estimate the model parameters in this scenario is a significant task. The model probabilities corresponding to the observed proportions cannot be evaluated exactly, and so they are estimated within the inference algorithm by repeatedly simulating realizations from the model. In general such an approach is computationally very expensive, and we therefore construct Gaussian process emulators for the key quantities and reformulate our algorithm around these fast stochastic approximations. We conclude by highlighting appropriate values of the model parameters leading to new insights into the underlying biological processes.

SiM Other · 发表于 2021-05-06

Nowcasting COVID‐19 incidence indicators during the Italian first outbreak

Pierfrancesco Alaimo Di Loro, Fabio Divino, Alessio Farcomeni, Giovanna Jona Lasinio, Gianfranco Lovison, Antonello Maruotti, Marco Mingione

摘要

A novel parametric regression model is proposed to fit incidence data typically collected during epidemics. The proposal is motivated by real‐time monitoring and short‐term forecasting of the main epidemiological indicators within the first outbreak of COVID‐19 in Italy. Accurate short‐term predictions, including the potential effect of exogenous or external variables are provided. This ensures to accurately predict important characteristics of the epidemic (e.g., peak time and height), allowing for a better allocation of health resources over time. Parameter estimation is carried out in a maximum likelihood framework. All computational details required to reproduce the approach and replicate the results are provided.

SiM Clinical Trials Survival Analysis · 发表于 2021-05-06

Novel application of a discrete time‐to‐event model for randomized oral immunotherapy clinical trials with repeat food challenges

Natasha Purington, Sandra Andorf, Bryan Bunning, Sharon Chinthrajah, Kari Nadeau, Manisha Desai

摘要

The evaluation of double‐blind, placebo‐controlled food challenges (DBPCFC) generally focuses on a participant passing a challenge at a predetermined dose, and does not consider the dose of reaction for those who fail or are censored due to study discontinuation. Further, a number of food allergy trials have incorporated multiple DBPCFCs throughout the duration of the study in order to evaluate changes in reaction over time including sustained unresponsiveness from treatment. Outcomes arising from these trials are commonly modeled using Chi‐squared or Fisher's exact tests at each time point. We propose applying time‐to‐event methodology to food allergy trials in order to exploit the inherent granularity of challenge outcomes that additionally accommodates repeated DBPCFCs. Specifically, we consider dose‐to‐failure for each study challenge and extend the cumulative tolerated dose across challenges to result in a dose‐time axis. A discrete time‐to‐event framework is applied to the dose‐time outcome to assess the efficacy of treatment across the entire study period. We illustrate ideas with data from the Peanut Oral Immunotherapy Study: Safety, Efficacy and Discovery (POISED) trial, conducted at Stanford University, which evaluated the efficacy of oral immunotherapy on desensitization and sustained unresponsiveness in peanut allergic children and adults. We demonstrate the advantages of time‐to‐event approaches for assessing the efficacy of treatment over time and incorporating information for those who failed or were lost to follow up. Further, we introduce a dose‐time outcome that is interpretable to clinicians and allows for examination of such outcomes over time.

Biometrics Survival Analysis Testing & Uncertainty · 发表于 2021-05-06

A consistent version of distance covariance for right‐censored survival data and its application in hypothesis testing

Dominic Edelmann, Thomas Welchowski, Axel Benner

摘要

Distance covariance is a powerful new dependence measure that was recently introduced by Székely et al. and Székely and Rizzo. In this work, the concept of distance covariance is extended to measuring dependence between a covariate vector and a right‐censored survival endpoint by establishing an estimator based on an inverse‐probability‐of‐censoring weighted U‐statistic. The consistency of the novel estimator is derived. In a large simulation study, it is shown that induced distance covariance permutation tests show a good performance in detecting various complex associations. Applying the distance covariance permutation tests on a gene expression dataset from breast cancer patients outlines its potential for biostatistical practice.

SMMR Other · 发表于 2021-05-05

Improving the estimation of the COVID-19 effective reproduction number using nowcasting

Joaquin Salas

摘要

As the interactions between people increases, the impending menace of COVID-19 outbreaks materializes, and there is an inclination to apply lockdowns. In this context, it is essential to have easy-to-use indicators for people to employ as a reference. The effective reproduction number of confirmed positives, Rt, fulfills such a role. This document proposes a data-driven approach to nowcast Rt based on previous observations’ statistical behavior. As more information arrives, the method naturally becomes more precise about the final count of confirmed positives. Our method’s strength is that it is based on the self-reported onset of symptoms, in contrast to other methods that use the daily report’s count to infer this quantity. We show that our approach may be the foundation for determining useful epidemy tracking indicators.

SiM Diagnostics & Prediction · 发表于 2021-05-05

Developing more generalizable prediction models from pooled studies and large clustered data sets

Valentijn M. T. de Jong, Karel G. M. Moons, Marinus J. C. Eijkemans, Richard D. Riley, Thomas P. A. Debray

摘要

Prediction models often yield inaccurate predictions for new individuals. Large data sets from pooled studies or electronic healthcare records may alleviate this with an increased sample size and variability in sample characteristics. However, existing strategies for prediction model development generally do not account for heterogeneity in predictor‐outcome associations between different settings and populations. This limits the generalizability of developed models (even from large, combined, clustered data sets) and necessitates local revisions. We aim to develop methodology for producing prediction models that require less tailoring to different settings and populations. We adopt internal‐external cross‐validation to assess and reduce heterogeneity in models' predictive performance during the development. We propose a predictor selection algorithm that optimizes the (weighted) average performance while minimizing its variability across the hold‐out clusters (or studies). Predictors are added iteratively until the estimated generalizability is optimized. We illustrate this by developing a model for predicting the risk of atrial fibrillation and updating an existing one for diagnosing deep vein thrombosis, using individual participant data from 20 cohorts (N = 10 873) and 11 diagnostic studies (N = 10 014), respectively. Meta‐analysis of calibration and discrimination performance in each hold‐out cluster shows that trade‐offs between average and heterogeneity of performance occurred. Our methodology enables the assessment of heterogeneity of prediction model performance during model development in multiple or clustered data sets, thereby informing researchers on predictor selection to improve the generalizability to different settings and populations, and reduce the need for model tailoring. Our methodology has been implemented in the R package metamisc .

SiM Survival Analysis Missing Data & Measurement Error · 发表于 2021-05-05

A multistate survival model of the natural history of cancer using data from screened and unscreened population

Rikesh Bhatt, Ardo van den Hout, Nora Pashayan

摘要

One of the main aims of models using cancer screening data is to determine the time between the onset of preclinical screen‐detectable cancer and the onset of the clinical state of the cancer. This time is called the sojourn time. One problem in using screening data is that an individual can be observed in preclinical phase or clinically diagnosed but not both. Multistate survival models provide a method of modeling the natural history of cancer. The natural history model allows for the calculation of the sojourn time. We developed a continuous‐time Markov model and the corresponding likelihood function. The model allows for the use of interval‐censored, left‐truncated and right‐censored data. The model uses data of clinically diagnosed cancers from both screened and nonscreened individuals. Parameters of age‐varying hazards and age‐varying misclassification are estimated simultaneously. The mean sojourn time is calculated from a micro‐simulation using model parameters. The model is applied to data from a prostate screening trial. The simulation study showed that the model parameters could be estimated accurately.

SiM Causal Inference Survival Analysis · 发表于 2021-05-04

Using generalized linear models to implement g‐estimation for survival data with time‐varying confounding

Shaun R. Seaman, Ruth H. Keogh, Oliver Dukes, Stijn Vansteelandt

摘要

Using data from observational studies to estimate the causal effect of a time‐varying exposure, repeatedly measured over time, on an outcome of interest requires careful adjustment for confounding. Standard regression adjustment for observed time‐varying confounders is unsuitable, as it can eliminate part of the causal effect and induce bias. Inverse probability weighting, g‐computation, and g‐estimation have been proposed as being more suitable methods. G‐estimation has some advantages over the other two methods, but until recently there has been a lack of flexible g‐estimation methods for a survival time outcome. The recently proposed Structural Nested Cumulative Survival Time Model (SNCSTM) is such a method. Efficient estimation of the parameters of this model required bespoke software. In this article we show how the SNCSTM can be fitted efficiently via g‐estimation using standard software for fitting generalised linear models. The ability to implement g‐estimation for a survival outcome using standard statistical software greatly increases the potential uptake of this method. We illustrate the use of this method of fitting the SNCSTM by reanalyzing data from the UK Cystic Fibrosis Registry, and provide example R code to facilitate the use of this approach by other researchers.

Biometrics Survival Analysis · 发表于 2021-05-04

Stratified Cox models with time‐varying effects for national kidney transplant patients: A new blockwise steepest ascent method

Kevin He, Ji Zhu, Jian Kang, Yi Li

摘要

Analyzing the national transplant database, which contains about 300,000 kidney transplant patients treated in over 290 transplant centers, may guide the disease management and inform the policy of kidney transplantation. Cox models stratified by centers provide a convenient means to account for the clustered data structure, while studying more than 160 predictors with effects that may vary over time. As fitting a time‐varying effect model with such a large sample size may defy any existing software, we propose a blockwise steepest ascent procedure by leveraging the block structure of parameters inherent from the basis expansions for each coefficient function. The algorithm iteratively updates the optimal blockwise search direction, along which the increment of the partial likelihood is maximized. The proposed method can be interpreted from the perspective of the minorization‐maximization algorithm and increases the partial likelihood until convergence. We further propose a Wald statistic to test whether the effects are indeed time varying. We evaluate the utility of the proposed method via simulations. Finally, we apply the method to analyze the national kidney transplant data and detect the time‐varying nature of the effects of various risk factors.

Biometrics Longitudinal Data Causal Inference Survival Analysis · 发表于 2021-05-04

Quantifying direct and indirect effect for longitudinal mediator and survival outcome using joint modeling approach

Cheng Zheng, Lei Liu

摘要

Longitudinal biomarkers are widely used in biomedical and translational researches to monitor the progressions of diseases. Methods have been proposed to jointly model longitudinal data and survival data, but its causal mechanism is yet to be investigated rigorously. Understanding how much of the total treatment effect is through the biomarker is important in understanding the treatment mechanism and evaluating the biomarker. In this work, we propose a causal mediation analysis method to compute the direct and indirect effects, when a joint modeling approach is used to take the longitudinal biomarker as the mediator and the survival endpoint as the outcome. Such a joint modeling approach allows us to relax the commonly used “sequential ignorability” assumption. We demonstrate how to evaluate longitudinally measured biomarkers using our method with two case studies, an AIDS study and a liver cirrhosis study.

JASA Bayesian Methods Missing Data & Measurement Error · 发表于 2021-05-04

Generalized Bayes Quantification Learning under Dataset Shift

Jacob Fiksel, Abhirup Datta, Agbessi Amouzou, Scott Zeger

摘要

Quantification learning is the task of prevalence estimation for a test population using predictions from a classifier trained on a different population. Quantification methods assume that the sensitivities and specificities of the classifier are either perfect or transportable from the training to the test population. These assumptions are inappropriate in the presence of dataset shift, when the misclassification rates in the training population are not representative of those for the test population. Quantification under dataset shift has been addressed only for single-class (categorical) predictions and assuming perfect knowledge of the true labels on a small subset of the test population. We propose generalized Bayes quantification learning (GBQL) that uses the entire compositional predictions from probabilistic classifiers and allows for uncertainty in true class labels for the limited labeled test data. Instead of positing a full model, we use a model-free Bayesian estimating equation approach to compositional data based only on a first-moment assumption. The idea will be useful in Bayesian compositional data analysis in general as it is robust to different generating mechanisms for compositional data and includes categorical outputs as a special case. We show how our method yields existing quantification approaches as special cases. Extension to an ensemble GBQL that uses predictions from multiple classifiers yielding inference robust to inclusion of a poor classifier is discussed. We outline a fast and efficient Gibbs sampler using a rounding and coarsening approximation to the loss functions. We also establish posterior consistency, asymptotic normality and valid coverage of interval estimates from GBQL, as well as finite sample posterior concentration rate. Empirical performance of GBQL is demonstrated through simulations and analysis of real data with evident dataset shift. *(abstract via OpenAlex)*

SiM Other · 发表于 2021-05-04

Degrees of necessity and of sufficiency: Further results and extensions, with an application to covid‐19 mortality in Austria

Andreas Gleiss, Robin Henderson, Michael Schemper

摘要

The purpose of this paper is to extend to ordinal and nominal outcomes the measures of degree of necessity and of sufficiency defined by the authors for dichotomous and survival outcomes in a previous paper. A cause, represented by certain values of prognostic factors, is considered necessary for an event if, without the cause, the event cannot develop. It is considered sufficient for an event if the event is unavoidable in the presence of the cause. The degrees of necessity and sufficiency, ranging from zero to one, are simple, intuitive functions of unconditional and conditional probabilities of an event such as disease or death. These probabilities often will be derived from logistic regression models; the measures, however, do not require any particular model. In addition, we study in detail the relationship between the proposed measures and the related explained variation summary for dichotomous outcomes, which are the common root for the developments for ordinal, nominal, and survival outcomes. We introduce and analyze the Austrian covid‐19 data, with the aim of quantifying effects of age and other potentially prognostic factors on covid‐19 mortality. This is achieved by standard regression methods but also in terms of the newly proposed measures. It is shown how they complement the toolbox of prognostic factor studies, in particular when comparing the importance of prognostic factors of different types. While the full model's degree of necessity is extremely high (0.933), its low degree of sufficiency (0.179) is responsible for the low proportion of explained variation (0.193).

JASA Spatial & Time Series Econometrics & Economics Genetics & Omics · 发表于 2021-05-04

Count Time Series: A Methodological Review

Richard A. Davis, Konstantinos Fokianos, Scott H. Holan, Harry Joe, James Livsey, Robert Lund, Vladas Pipiras, Nalini Ravishanker

摘要

A growing interest in non-Gaussian time series, particularly in series comprised of nonnegative integers (counts), is taking place in today’s statistics literature. Count series naturally arise in fields, such as agriculture, economics, epidemiology, finance, geology, meteorology, and sports. Unlike stationary Gaussian series where autoregressive moving-averages are the primary modeling vehicle, no single class of models dominates the count landscape. As such, the literature has evolved somewhat ad-hocly, with different model classes being developed to tackle specific situations. This article is an attempt to summarize the current state of count time series modeling. The article first reviews models having prescribed marginal distributions, including some recent developments. This is followed by a discussion of state-space approaches. Multivariate extensions of the methods are then studied and Bayesian approaches to the problem are considered. The intent is to inform researchers and practitioners about the various types of count time series models arising in the modern literature. While estimation issues are not pursued in detail, reference to this literature is made. *(abstract via OpenAlex)*

JASA Missing Data & Measurement Error · 发表于 2021-05-04

Balancing Inferential Integrity and Disclosure Risk Via Model Targeted Masking and Multiple Imputation

Bei Jiang, Adrian E. Raftery, Russell J. Steele, Naisyin Wang

摘要

There is a growing expectation that data collected by government-funded studies should be openly available to ensure research reproducibility, and so is the concern on data-privacy. A strategy to protect individuals' identity is to release multiply imputed (MI) synthetic datasets with masked sensitivity values (Rubin, 1993). However, information loss or incorrectly specified imputation models can weaken or invalidate the inferences obtained from the MI-datasets. Studying a restricted-use Canadian Scleroderma Research Group (CSRG) dataset, the authors investigate the use of a new masking framework with a data-augmentation (DA) component and a tuning mechanism that balances between protecting identity-disclosure and preserving data-utility. They found, respectively in a work-disability and an interstitial lung disease study, using this DA-MI strategy reached 0% identity disclosure-risk, preserved all inferential conclusions, and on average produced 98.5% and 95.5% confidence intervals (CI) overlaps when compared to the 95% CIs constructed using the generic CSGR dataset; the lowest CI-overlap value is 91%. In contrast, the same is not true for the currently used methods; with the CI-overlap values ranging from 73.9% to 91.8% and the lowest value being 28.1%. These findings indicate that the DA-MI masking framework facilitates sharing of useful research data while protecting participants' identities. *(abstract via PubMed)*

Biometrics Other · 发表于 2021-05-04

A transformation‐free linear regression for compositional outcomes and predictors

Jacob Fiksel, Scott Zeger, Abhirup Datta

摘要

Compositional data are common in many fields, both as outcomes and predictor variables. The inventory of models for the case when both the outcome and predictor variables are compositional is limited, and the existing models are often difficult to interpret in the compositional space, due to their use of complex log‐ratio transformations. We develop a transformation‐free linear regression model where the expected value of the compositional outcome is expressed as a single Markov transition from the compositional predictor. Our approach is based on estimating equations thereby not requiring complete specification of data likelihood and is robust to different data‐generating mechanisms. Our model is simple to interpret, allows for 0s and 1s in both the compositional outcome and covariates, and subsumes several interesting subcases of interest. We also develop permutation tests for linear independence and equality of effect sizes of two components of the predictor. Finally, we show that despite its simplicity, our model accurately captures the relationship between compositional data using two datasets from education and medical research.

Biometrics Genetics & Omics Econometrics & Economics · 发表于 2021-05-04

A generalized robust allele‐based genetic association test

Lin Zhang, Lei Sun

摘要

The allele‐based association test, comparing allele frequency difference between case and control groups, is locally most powerful. However, application of the classical allelic test is limited in practice, because the method is sensitive to the Hardy–Weinberg equilibrium (HWE) assumption, not applicable to continuous traits, and not easy to account for covariate effect or sample correlation. To develop a generalized robust allelic test, we propose a new allele‐based regression model with individual allele as the response variable. We show that the score test statistic derived from this robust and unifying regression framework contains a correction factor that explicitly adjusts for potential departure from HWE and encompasses the classical allelic test as a special case. When the trait of interest is continuous, the corresponding allelic test evaluates a weighted difference between individual‐level allele frequency estimate and sample estimate where the weight is proportional to an individual's trait value, and the test remains valid under Y ‐dependent sampling. Finally, the proposed allele‐based method can analyze multiple (continuous or binary) phenotypes simultaneously and multiallelic genetic markers, while accounting for covariate effect, sample correlation, and population heterogeneity. To support our analytical findings, we provide empirical evidence from both simulation and application studies.

第 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 页